J-GLOBAL ID:201801006790535517   Update date: Aug. 31, 2020

Bin Li

リ ビン | Bin Li
Affiliation and department:
Research field  (1): Tumor biology
Research keywords  (5): AMPK ,  SERM ,  ヒト子宮筋腫モデルマウス ,  子宮筋腫 ,  ELT-3細胞
Research theme for competitive and other funds  (2):
  • 2013 - 2016 新規選択的エストロゲン受容体モジュレーターによる子宮筋腫治療薬開発
  • 2010 - 2011 子宮筋腫細胞増殖・線維化における、低酸素細胞内シグナル伝達機構解析
Papers (22):
MISC (12):
Patents (1):
  • 子宮筋腫細胞増殖抑制剤
Lectures and oral presentations  (8):
  • Clinical Biobank in INGEM
    (Collaborative Seminar by Tohoku University and CEA, France Toward the Next Generation Medicine 2018)
  • Investigate the Inhibitory Effect of SS5020-A Selective Estrogen Receptor Modulator on UterineLeiomyomas
    (63rd Society for Reproductive Investigation 2016)
  • Improvement of bioavailability and apoptosis potential of curcumin in combination with epigallocatechin-3-gallate in leiomyosarcoma cells
    (62nd Society for Reproductive Investigation 2015)
  • Comparison between Chinese gynecological cancer-care and Japanese gynecological cancer-care
    (International symposium of PHRDC (Promotion Plan for the Platform of Human Resource Development for Cancer) 2014 in Iwate 2014)
  • Curcumin induces cross-regulation between autophagy and apoptosis in uterine leiomyosarcoma cells
    (65th JSOG (Japan Society of Obstetrics and Gynecology) Annual Meeting in Hokaido 2013)
Professional career (1):
  • 医学博士 (東北大学)
Awards (1):
  • IS Good Poster Award
Association Membership(s) (2):
Japan Society of Obstetrics and Gyneology ,  Japan Society of Biochemistry and Molecular Biology
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page